Investigating the role of SOX9 in liver fibrosis
研究 SOX9 在肝纤维化中的作用
基本信息
- 批准号:MR/J003352/1
- 负责人:
- 金额:$ 57.78万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2012
- 资助国家:英国
- 起止时间:2012 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Liver fibrosis is a devastating scarring reaction that results from injury to the liver (e.g. by alcohol or infection). The scarring impairs liver function. The ultimate treatment of liver fibrosis is transplantation. Unfortunately this is limited due to the high numbers of people in need of a transplant. For this reason, identifying effective anti-fibrotic treatments at early stages of disease would be hugely beneficial. To achieve this better understanding of how the scar forms is needed. Although progress has been made in this area, unfortunately there are still no approved anti fibrotic treatments. To tackle this problem, I have identified SOX9 as a core factor responsible for mediating large components of scar formation. It is now essential to determine whether loss of SOX9 can be used as a means of reversing scar formation and ultimately fibrosis in the liver. This project will develop models to test whether loss of Sox9 prevents or ameliorates liver fibrosis and if over-expression of Sox9 worsens or accelerates the disease. In addition, I will discover what other genes lie downstream of SOX9 and integrate these with known signalling pathways important in liver fibrosis to uncover new targets and potential for therapies against liver fibrosis.Taken together, these experiments are anticipated to prove an important role for Sox9 in organ fibrosis and assist in identifying new pathways of value in the search for new therapies.
肝纤维化是一种破坏性的疤痕反应,由肝脏损伤(例如酒精或感染)引起。疤痕会损害肝功能。肝纤维化的最终治疗方法是肝移植。不幸的是,这是有限的,由于大量的人需要移植。因此,在疾病的早期阶段确定有效的抗纤维化治疗将是非常有益的。为了实现这一目标,需要更好地了解疤痕是如何形成的。虽然在这方面已经取得了进展,但不幸的是,仍然没有批准的抗纤维化治疗。为了解决这个问题,我已经将SOX 9确定为负责介导瘢痕形成的大部分的核心因子。现在必须确定SOX 9的丢失是否可以用作逆转肝脏瘢痕形成和最终纤维化的手段。该项目将开发模型来测试Sox 9的缺失是否可以预防或改善肝纤维化,以及Sox 9的过度表达是否会加速或加重疾病。此外,我还将发现SOX9下游的其他基因,并将这些基因与已知的肝纤维化重要信号通路整合,以发现新的靶点和抗肝纤维化治疗的潜力。总之,这些实验有望证明SOX9在器官纤维化中的重要作用,并有助于确定新的有价值的通路,以寻找新的治疗方法。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.
- DOI:10.15252/emmm.201707860
- 发表时间:2017-12
- 期刊:
- 影响因子:11.1
- 作者:Athwal VS;Pritchett J;Llewellyn J;Martin K;Camacho E;Raza SM;Phythian-Adams A;Birchall LJ;Mullan AF;Su K;Pearmain L;Dolman G;Zaitoun AM;Friedman SL;MacDonald A;Irving WL;Guha IN;Hanley NA;Piper Hanley K
- 通讯作者:Piper Hanley K
The epigenomic landscape regulating organogenesis in human embryos linked to developmental disorders
调节与发育障碍相关的人类胚胎器官发生的表观基因组景观
- DOI:10.1101/691766
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Gerrard D
- 通讯作者:Gerrard D
Laser Capture and Deep Sequencing Reveals the Transcriptomic Programmes Regulating the Onset of Pancreas and Liver Differentiation in Human Embryos.
- DOI:10.1016/j.stemcr.2017.09.018
- 发表时间:2017-11-14
- 期刊:
- 影响因子:5.9
- 作者:Jennings RE;Berry AA;Gerrard DT;Wearne SJ;Strutt J;Withey S;Chhatriwala M;Piper Hanley K;Vallier L;Bobola N;Hanley NA
- 通讯作者:Hanley NA
Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes.
- DOI:10.1016/j.jhep.2014.10.016
- 发表时间:2015-03
- 期刊:
- 影响因子:25.7
- 作者:Baxter, Melissa;Withey, Sarah;Harrison, Sean;Segeritz, Charis-Patricia;Zhang, Fang;Atkinson-Dell, Rebecca;Rowe, Cliff;Gerrard, Dave T.;Sison-Young, Rowena;Jenkins, Roz;Henry, Joanne;Berry, Andrew A.;Mohamet, Lisa;Best, Marie;Fenwick, Stephen W.;Malik, Hassan;Kitteringham, Neil R.;Goldring, Chris E.;Hanley, Karen Piper;Vallier, Ludovic;Hanley, Neil A.
- 通讯作者:Hanley, Neil A.
SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis
- DOI:10.1038/s41598-018-36037-4
- 发表时间:2018-12-17
- 期刊:
- 影响因子:4.6
- 作者:Athwal, Varinder S.;Pritchett, James;Hanley, Karen Piper
- 通讯作者:Hanley, Karen Piper
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen Piper Hanley其他文献
Aetiology of Significant Liver Test Abnormalities in a Single-Centre Cohort of People with Cystic Fibrosis Exposed to Elexacaftor/Tezacaftor/Ivacaftor, Utilizing the Updated RUCAM
利用更新的 RUCAM,暴露于 Elexacaftor/Tezacaftor/Ivacaftor 的单中心囊性纤维化患者队列中显着肝脏测试异常的病因学
- DOI:
10.1007/s40265-023-01969-3 - 发表时间:
2023 - 期刊:
- 影响因子:11.5
- 作者:
D. Tewkesbury;Andrew M Jones;R. Bright;A. Cratchley;Karen Piper Hanley;Judith Wyatt;V. Athwal;Peter J Barry - 通讯作者:
Peter J Barry
OS-109 Developmental gene regulatory networks driving human liver disease cell states identified by single cell multi-modal data integration
- DOI:
10.1016/s0168-8278(24)00550-6 - 发表时间:
2024-06-01 - 期刊:
- 影响因子:
- 作者:
Nigel Hammond;Elliot Jokl;Syed Murtuza-Baker;Sokratia Georgaka;Varinder Athwal;Neil Hanley;Karen Piper Hanley - 通讯作者:
Karen Piper Hanley
OS152 - Integrating single-cell RNA and spatial transcriptomic data defines altered cell state in human liver fibrosis
OS152 - 整合单细胞 RNA 和空间转录组学数据定义了人类肝纤维化中改变的细胞状态
- DOI:
10.1016/s0168-8278(22)00598-0 - 发表时间:
2022-07-01 - 期刊:
- 影响因子:33.000
- 作者:
Nigel Hammond;Sokratia Georgaka;Syed Murtuza-Baker;Ali Al-Anbaki;Elliot Jokl;Harry Spiers;Ajith Siriwardena;Varinder Athwal;Neil Hanley;Magnus Rattray;Karen Piper Hanley - 通讯作者:
Karen Piper Hanley
OS-097 - CLOCKΔ19 circadian disruption primes myofibroblasts for accelerated activation and fibrotic progression
- DOI:
10.1016/s0168-8278(23)00550-0 - 发表时间:
2023-06-01 - 期刊:
- 影响因子:
- 作者:
Elliot Jokl;Jessica Llewelyn;Kara Simpson;Oluwatobi Adegboye;James Pritchett;Leo Zeef;Qing-Jun Meng;Karen Piper Hanley - 通讯作者:
Karen Piper Hanley
Transcriptional regulation of the Alström syndrome gene <em>ALMS1</em> by members of the RFX family and Sp1
- DOI:
10.1016/j.gene.2010.03.015 - 发表时间:
2010-07-15 - 期刊:
- 影响因子:
- 作者:
Tracey L. Purvis;Tom Hearn;Cosma Spalluto;Victoria J. Knorz;Karen Piper Hanley;Tilman Sanchez-Elsner;Neil A. Hanley;David I. Wilson - 通讯作者:
David I. Wilson
Karen Piper Hanley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen Piper Hanley', 18)}}的其他基金
Interrogating ITGA11 signalling in rodent and human for targeted anti-fibrotic therapy in liver fibrosis.
探究啮齿动物和人类的 ITGA11 信号传导,以用于肝纤维化的靶向抗纤维化治疗。
- 批准号:
MR/P023541/1 - 财政年份:2017
- 资助金额:
$ 57.78万 - 项目类别:
Research Grant
相似国自然基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
- 批准号:82371070
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
The role of the TGFB-SOX9 signaling pathway in brain angiogenesis
TGFB-SOX9信号通路在脑血管生成中的作用
- 批准号:
463116 - 财政年份:2022
- 资助金额:
$ 57.78万 - 项目类别:
Operating Grants
Establishing Sox9 as a regulator of intrahepatic bile duct development and regeneration
建立 Sox9 作为肝内胆管发育和再生的调节因子
- 批准号:
10537874 - 财政年份:2022
- 资助金额:
$ 57.78万 - 项目类别:
Role of SOX9 mammary stem cell factor in metastasis
SOX9乳腺干细胞因子在转移中的作用
- 批准号:
10408966 - 财政年份:2022
- 资助金额:
$ 57.78万 - 项目类别:
Establishing Sox9 as a regulator of intrahepatic bile duct development and regeneration
建立 Sox9 作为肝内胆管发育和再生的调节因子
- 批准号:
10656256 - 财政年份:2022
- 资助金额:
$ 57.78万 - 项目类别:
Role of SOX9 mammary stem cell factor in metastasis
SOX9乳腺干细胞因子在转移中的作用
- 批准号:
10659157 - 财政年份:2022
- 资助金额:
$ 57.78万 - 项目类别:
Sox9 Regulation of Fibroblast Activation and Pulmonary Fibrosis
Sox9 对成纤维细胞活化和肺纤维化的调节
- 批准号:
10180163 - 财政年份:2021
- 资助金额:
$ 57.78万 - 项目类别:
Sox9 Regulation of Fibroblast Activation and Pulmonary Fibrosis
Sox9 对成纤维细胞活化和肺纤维化的调节
- 批准号:
10620706 - 财政年份:2021
- 资助金额:
$ 57.78万 - 项目类别:
Sox9 Regulation of Fibroblast Activation and Pulmonary Fibrosis
Sox9 对成纤维细胞活化和肺纤维化的调节
- 批准号:
10461725 - 财政年份:2021
- 资助金额:
$ 57.78万 - 项目类别:
Defining the developmental and toxicological roles of the AHR-regulated Sox9 lncRNA in zebrafish
定义 AHR 调节的 Sox9 lncRNA 在斑马鱼中的发育和毒理学作用
- 批准号:
10088447 - 财政年份:2019
- 资助金额:
$ 57.78万 - 项目类别:
SOX9 Expression Identifies A Novel Alveolar Stem Cell Population
SOX9 表达鉴定出新型肺泡干细胞群
- 批准号:
10307615 - 财政年份:2018
- 资助金额:
$ 57.78万 - 项目类别: